Effects, Tolerance, and Response to COVID-19 Vaccines in Hispanic Puerto Rican Patients with Multiple Sclerosis
Background: At the start of the SARS-CoV-2 (COVID-19) pandemic there was uncertainty among Multiple Sclerosis (MS) patients about starting...
Oligoclonal Band Negative Multiple Sclerosis in Puerto Rico
Background: The incidence of multiple sclerosis (MS) in Puerto Rico (PR) is higher than in other Latin American and Caribbean countries....
Evidence of Distress By Multiple Sclerosis (MS) Patient Caregiver As a Consequence of COVID-19
Background: Multiple Sclerosis (MS) is a demyelinating condition that leads to progressive weakness and disability often resulting in...
Positive Outcome with Alemtuzumab in Hispanic Puerto Rican Woman with Highly Active Multiple Sclerosis after Various Failed Disease Modifying Therapies
Background: Multiple sclerosis (MS) is the most common autoimmune demyelinating disease of the central nervous system (CNS). It is an...